Skip to main content
. 2017 Feb 20;7(4):522–532. doi: 10.1002/2211-5463.12200

Figure 1.

Figure 1

Myostatin treatment induces tenogenic differentiation and inhibits adipogenic and myogenic differentiation. (A) Relative expression of the tenogenic markers tenomodulin and scleraxis in C2C12 cells treated with GDF‐5, ‐6, ‐7, and ‐8 (myostatin) for 5 days. (B) Relative expression of adipogenic markers (CEBPβ and PPARγ) and myogenic markers (myogenin and MyoD) in C2C12 cells treated with or without myostatin for 5 days. Values represent the mean relative expression ± SEM. N = 4. *Statistically significant, P < 0.05.